Drug Bioequivalence Metadata
Metadata describes a digital item, providing (if known) such information as creator, publisher, contents, size, relationship to other resources, and more. Metadata may also contain "preservation" components that help us to maintain the integrity of digital files over time.
- Main Title Drug Bioequivalence
Author: United States. Congress. Office of Technology Assessment. Drug Bioequivalence Study Panel.Creator Type: Organization
Name: United States. Congress. Office of Technology Assessment.Place of Publication: [Washington D.C.]
- Creation: 1974-07
- Content Description: Report of the findings from a panel of the Office of Technology Assessment (OTA) regarding drug bioequivalence therapies. According to the report, the purpose of the Drug Bioequivalence Study Panel "was to examine the relationships between the chemical and therapeutic equivalence of drug products and to assess the capability of current technology -- short of therapeutic trials in man -- to determine whether drug products with the same physical and chemical composition produce comparable therapeutic effects" (p. 5).
- Physical Description: 78 p. ; 28 cm.
- Library of Congress Subject Headings: Drugs -- Therapeutic equivalency -- Research.
- Library of Congress Subject Headings: Drugs -- Therapeutic equivalency -- Experiments.
- Library of Congress Subject Headings: Bioavailability -- United States.
- Keyword: standards
- Keyword: drug policies
- Keyword: drug therapies
- Keyword: drug trials
- Keyword: bioequivalency
- Place Name: United States
- Coverage Date: 1974
Name: Office of Technology AssessmentCode: OTA
Name: UNT Libraries Government Documents DepartmentCode: UNTGD
- Archival Resource Key: ark:/67531/metadc39335
- Display Note: The original does not have a page 4.